全文获取类型
收费全文 | 22800篇 |
免费 | 1579篇 |
国内免费 | 129篇 |
专业分类
耳鼻咽喉 | 181篇 |
儿科学 | 551篇 |
妇产科学 | 790篇 |
基础医学 | 2829篇 |
口腔科学 | 1274篇 |
临床医学 | 2228篇 |
内科学 | 5850篇 |
皮肤病学 | 518篇 |
神经病学 | 976篇 |
特种医学 | 514篇 |
外科学 | 2426篇 |
综合类 | 190篇 |
一般理论 | 4篇 |
预防医学 | 2342篇 |
眼科学 | 385篇 |
药学 | 1851篇 |
2篇 | |
中国医学 | 387篇 |
肿瘤学 | 1210篇 |
出版年
2023年 | 704篇 |
2022年 | 852篇 |
2021年 | 941篇 |
2020年 | 1002篇 |
2019年 | 715篇 |
2018年 | 890篇 |
2017年 | 934篇 |
2016年 | 985篇 |
2015年 | 697篇 |
2014年 | 1247篇 |
2013年 | 1052篇 |
2012年 | 1267篇 |
2011年 | 1312篇 |
2010年 | 1075篇 |
2009年 | 969篇 |
2008年 | 1039篇 |
2007年 | 1096篇 |
2006年 | 1106篇 |
2005年 | 889篇 |
2004年 | 758篇 |
2003年 | 738篇 |
2002年 | 667篇 |
2001年 | 590篇 |
2000年 | 537篇 |
1999年 | 520篇 |
1998年 | 207篇 |
1997年 | 65篇 |
1996年 | 62篇 |
1995年 | 59篇 |
1994年 | 41篇 |
1993年 | 35篇 |
1992年 | 223篇 |
1991年 | 219篇 |
1990年 | 197篇 |
1989年 | 171篇 |
1988年 | 182篇 |
1987年 | 112篇 |
1986年 | 17篇 |
1985年 | 30篇 |
1984年 | 26篇 |
1983年 | 26篇 |
1982年 | 31篇 |
1981年 | 24篇 |
1980年 | 29篇 |
1979年 | 23篇 |
1978年 | 13篇 |
1976年 | 14篇 |
1974年 | 12篇 |
1973年 | 20篇 |
1972年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《HPB : the official journal of the International Hepato Pancreato Biliary Association》2022,24(6):974-985
BackgroundThe futility of liver transplantation in elderly recipients remains under debate in the HCV eradication era.MethodsThe aim was to assess the effect of older age on outcome after liver transplantation. We used the ELTR to study the relationship between recipient age and post-transplant outcome. Young and elderly recipients were compared using a PSM method.ResultsA total of 10,172 cases were analysed. Recipient age >65 years was identified as an independent risk factor associated with reduced patient survival (HR:1.42 95%CI:1.23–1.65,p < 0.001). After PSM, 2124 patients were matched, and the same association was found between elderly recipients and patient survival and graft survival (p < 0.001). As hepatocellular carcinoma and alcoholic cirrhosis were independent prognostic factors for patient and graft survival a propensity score-matching was performed for each. Patient and graft survival were significantly worse (p < 0.05) in the alcoholic cirrhosis elderly group. However, patient and graft survival in the hepatocellular carcinoma cohort were similar (p > 0.05) between groups.ConclusionLiver transplantation is an acceptable and safe curative option for elderly transplant candidates, with worse long-term outcomes compare to young candidates. The underlying liver disease for liver transplantation has a significant impact on the selection of elderly patients. 相似文献
3.
Disparity in Utilization of Multiagent Therapy for Acute Promyelocytic Leukemia in the United States
《Clinical Lymphoma, Myeloma & Leukemia》2022,22(5):319-325
BackgroundDespite high rate of cure in acute promyelocytic leukemia (APL) in clinical trials, outcomes in real-world practice are dismal. We utilized National Cancer Database (NCDB) to explore utilization of multiagent therapy in APL and identify any disparities in treatment in real-world practices.Patients and MethodsNCDB categorizes use of systemic chemotherapy into single agent versus multiagent therapy. Some patients received hormonal therapy, immunotherapy, and unknown therapy; details of these treatments could not be ascertained. We therefore used multiple logistic regression analysis to evaluate effects of covariates on the probability of multiagent therapy use in 6678 patients.ResultsCompared to patients >60 years, patients aged 0 to 18 years (hazard ratio[HR] 3.2, 95% confidence interval [CI] 1.8-5.5, P< .0001), 19 to 40 years (HR 1.6, 95% CI 1.03-2.54, P= .03), and 41 to 60 years (HR 1.6, 95% CI 1.3-1.9, P< .0001) were more likely to receive multiagent therapy. Patients with Charlson comorbidity index (CCI) of 0 (HR 1.6, 95% CI 1.2-2.3, P= .001) and CCI of 1 (HR 1.4, 95% CI 1.0-1.9, P= .04) had a higher likelihood of receiving multiagent therapy than patients with CCI ≥ 3. Patients treated at academic cancer centers, compared to those treated at community cancer center (HR 0.5, 95% CI 0.3-0.7, P= .001), comprehensive community cancer center (HR 0.7, 95% CI 0.6-0.8, P< .0001), and integrated network cancer center (HR 0.8, 95% CI 0.6-0.9, P= .02) were more likely to be treated with multiagent therapy. Compared to the patients with private insurance, those with Medicaid had increased likelihood (HR 1.2, 95% CI 1.0-1.4, P= .04) whereas uninsured patients had a lower likelihood of receiving multiagent therapy (HR 0.6, 95% CI 0.5-0.8, P= .0005).ConclusionTo our knowledge, this study is the first and the largest scale analysis of treatment practices in APL in real-world practices. Our findings highlight significant disparities in treatment of APL based on age, insurance, and health-system factors. 相似文献
4.
《Current problems in cancer》2022,46(6):100896
Head and neck squamous cell carcinoma (HNSCC) is considered an immunosuppressive malignancy. Cross-talk between cancer cells and immune cells is modulated in part by CC ligand (CCL) chemokines, having a major effect on tumor progression. However, the predictive value and function of CCL family members in HNSCC have not been elucidated. Here, the predictive value of CCL members in cancer prognosis and Immune checkpoint blockade therapy response was investigated. CCL17 and CCL22 were screened as the key CCL chemokines in HNSCC through co-expression analysis. Further, the correlation between CCL17/CCL22 expression and cancer immune infiltration were evaluated based on TIMER and were validated by a set of scRNA-seq data. Moreover, the expression level of CCL17/CCL22 we evaluated to predict the response to Immune checkpoint blockade therapy in a panel of cancer types by using the TIDE database. Results indicated that CCL17/CCL22 had a high co-expression correlation and had a marginally statistical significance with the overall survival in HNSCC patients (P value = 0.057 and 0.055, respectively). Our findings showed high expression of CCL17/CCL22 was positively correlated with CD4+ T cell infiltration levels in HNSCCs and activate mTORC1 signaling pathway in CD4+ T cells. Further analysis from TIDE showed the high expression of CCL17/CCL22 might predict favorable responses to immune checkpoint blockade therapy in HNSCC patients. These findings provide an insight into the predictive roles of CCL17/CCL22 in HNSCC. 相似文献
5.
《Clinical therapeutics》2022,44(7):1012-1025
Statins, or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are the mainstay of treatment for hypercholesterolemia as they effectively reduce LDL-C levels and risk of atherosclerotic cardiovascular disease. Apart from hyperglycemia, dyslipidemia and HDL dysfunction are known risk factors for neuropathy in people with obesity and diabetes. Although there are case reports of statin-induced neuropathy, ad hoc analyses of clinical trials and observational studies have shown that statins may improve peripheral neuropathy. However, large randomized controlled trials and meta-analyses of cardiovascular outcome trials with statins and other lipid-lowering drugs have not reported on neuropathy outcomes. Because neuropathy was not a prespecified outcome in major cardiovascular trials, one cannot conclude whether statins or other lipid-lowering therapies increase or decrease the risk of neuropathy. The aim of this review was to assess if statins have beneficial or detrimental effects on neuropathy and whether there is a need for large well-powered interventional studies using objective neuropathy end points. 相似文献
6.
7.
8.
9.
10.